COmparing the use of Midline Catheters versus Peripherally Inserted Central CAtheters for patients requiring peripherally Compatible Therapies: A randomised controlled trial (the COMPACT Trial)
- Conditions
- Catheter failure prior to completion of therapyPublic Health - Health service researchInfection - Other infectious diseases
- Registration Number
- ACTRN12620000112965
- Lead Sponsor
- Griffith University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 25
• Informed consent to participate
• The treating team have referred the patient to receive a PICC with peripherally-compatible intravenous therapy
• Patient expected to receive IV therapy for up to or equal to 29 days
• The treating team has approved the use of either a MC or PICC.
• Non-English speakers without interpreter
• Patient receiving end-of-life care
• Patient with a history of venous thromboembolism or renal disease
• Cognitive barrier to consent (without a SDM)
• Previous enrolment in this study
• Patient receiving chemotherapy treatment
• Patient lives outside Metro North Hospital and Health Service.
• History of intravenous drug use in the last one year
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method